Parallel Bio
parallel.bioThe first map of human biology for drug discovery
Health & Wellnessdrug-discoverybiotechhuman-biologyprecision-medicinecomputational-biologybiobankpharma
About
Parallel Bio is a biotech company reimagining drug discovery by building a comprehensive map of human biology using human data instead of animal models. Their platform combines a growing biobank of patient samples with biological and computational tools to chart disease landscapes at population scale. They offer drug discovery, precision medicine, and foundation model capabilities to pharmaceutical partners, claiming 87% concordance with human outcomes and 10x faster timelines than traditional approaches.
Problem
97% of drugs fail in human trials because they are designed using animal models that don't accurately reflect human biology.
For
pharmaceutical companies and biotech researchers seeking human-first drug discovery
How it works
Parallel Bio builds a biological atlas entirely from human patient data using novel biological and computational tools, enabling population-scale, perturbable modeling of disease landscapes without animal testing.
Business model
unknown
Status
launched
Company
Parallel Bio